Partnering on vaccines to counter multi-drug resistant threats: Workshop proceedings, Biomedical Advanced Research and Development Authority

• Published in: Human vaccines & immunotherapeutics Vol. 18; no. 5; p. 2058840
• Main Authors: Bergmann, Julie N, Killen-Cade, Rushyannah R, Parish, Lindsay A, Albrecht, Mark T, Wolfe, Daniel N
• Format: Journal Article Conference Proceeding
• Language: English
• Published: United States Taylor & Francis 30.11.2022; Taylor & Francis Group
• Subjects: amr; Anti-Bacterial Agents - therapeutic use; antimicrobial resistance; Bacteria; barda; Drug Resistance, Bacterial; Escherichia coli; global health security; Licensed Vaccines – Meeting Report; Meeting Report; Microbial Sensitivity Tests; multi-drug resistance; Staphylococcus aureus; vaccine; Vaccines; BARDA; multi-drug resistance; vaccine; Antimicrobial resistance; AMR; global health security
• ISSN: 2164-5515; 2164-554X
• DOI: 10.1080/21645515.2022.2058840

On March 12, 2021, the Biomedical Advanced Research and Development Authority (BARDA) sponsored a virtual market research workshop, "Partnering on Vaccines to Counter Multi-Drug Resistant Threats," to discuss the threat of antimicrobial resistance in the context of BARDA's mission space and the challenges encountered during the development of vaccines for specific antimicrobial resistant bacteria. The workshop convened representatives with expertise in vaccine development from government, academia, and industry. This report summarizes the presentations and subsequent discussions from the workshop and highlights existing challenges to advance the development of vaccine candidates for antimicrobial resistant pathogens, including , and .